DRUG DISCOVERY SOLUTIONS

Toxin Purification & Purified Venom Products

In addition to our 2D fractionated arrays we also offer identified, purified venom components. These are often requested as positive controls in assays, research tools, or even as enzymes for manufacturing processes. Many of these requests follow publication of a specific toxin activity, demonstrating its potential use as a tool where small molecules have failed. Ion channel targets are an example.

Supply of purified venom products can also be the result of finding a hit from screening venom fractions and hit-to-lead confirmation.

In all cases, we work with our customers to confirm the molecule required and optimise and/or develop purification techniques. We can confirm identity through gel electrophoresis, mass spectrometry and, in the case of enzymes, activity.

Case Studies

Case Study 1 – Mambalgin-2

Since the 2012 discovery of venom peptides blocking Acid Sensing Ion Channels from the Black Mamba[1] (Dendroaspis polylepis), there has been growing interest in the use of these peptides to further understand this pain target. Mambalgin-1 and mambalgin-2 only differ by a single amino acid at position 4, namely tyrosine in mambalgin-1 and phenylalanine in mambalgin-2. This corresponds to a single hydroxyl group difference within the 6.5 kDa peptide. In collaboration with the University of Kent, we successfully provided pure mambalgin-2 from crude venom with greater than 99% purity. This work is currently being prepared for publication.

[1]Diochot et al, Nature, 2012 Oct 25; 490 (7421): 552-555

Case Study 2 – δ-theraphotoxin-Hm1a

MALRD TOF MS of purified Hm1a

In 2016, a cysteine knot peptide was discovered from the Togo Starburst spider (Heteroscodra maculata) that activates the pain relevant sodium channel NaV1.1[2] Theraphosid venoms, such as this, contain many similar peptides and thus purification was challenging. We successfully carried out the process and provided gel and MS data as standard.

[2]Osteen et al Nature, 2016 Jun 6; 534 (7608): 494–499

Case Study 3 – Phospholipase A2

Phospholipase A2 (PLA2) enzymes are key components of many venoms. They are typically small, at around 15KDa. Although their main function is hydrolysis of phospholipids, some have lost their catalytic activity and gained neurotoxic action. Malayan pit viper (Calloselasma rhodostoma) venom contains two PLA2 enzymes. These were purified separately and activity was confirmed for both enzymes.

Case Study 4 – Serine Protease

These enzymes are prevalent in Viperid snake venoms. They cause rapid blood coagulation through degradation of fibrinogen and then defibrination from digestion of fibrinopeptides. Serine protease was purified from Malayan pit viper venom and activity was confirmed in a plate based fibrinogen clotting assay.

 

Available products for cosmetics and drug discovery

Anti-inflammatory cosmetics

Anti-inflammatory 

Cosmetic peptides to soothe skin and reduce inflammation

Antipollutions skin toxins

Antipollution 

Cosmetic peptides to protect skin from toxins and pollutants

venom cosmetic peptide

VenomSELECTTM 

Our bespoke cosmetic peptide design service

Venom drug discovery

Target-based 

Target-based venom arrays for hard-to-hit drug targets

Therapeutic cancer research

Therapeutic areas 

Venom arrays for antimicrobial, pain, cancer research, etc.

Venom array drug discovery research

Custom Arrays 

Venom arrays designed by us for your target or research area

Drug Discovery Resources

Science Exchange

Do business via the world's leading and most secure R&D outsourcing platform

Papers & Posters

Helpful publications from our team, our partners and key industry sources

News & Media

Up-to-date events and news items about the species, the science and our team

FAQs

Find out more about our core and extended team, get in touch, collaborate!